HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
10 sources retrieved Β· Most recent: April 2026 Β· Index updated 15 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
SLC26A5
solute carrier family 26 member 5
Chromosome 7 Β· 7q22.1
NCBI Gene: 375611Ensembl: ENSG00000170615.16HGNC: HGNC:9359UniProt: P58743
61PubMed Papers
21Diseases
0Drugs
23Pathogenic Variants
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
protein bindingprotein homodimerization activitylateral plasma membranesensory perception of soundhearing losshearing loss, autosomal recessiveage-related hearing impairmentdeafness
✦AI Summary

SLC26A5 (prestin) is a voltage-sensitive motor protein that drives outer hair cell (OHC) electromotility, enabling sound amplification in the cochlea 1. The protein converts transmembrane electrical potential changes into mechanical displacements through a hybrid voltage-sensing mechanism involving both intrinsic charged amino acid residues and extrinsic chloride anion binding 2. Upon depolarization, anion binding transitions the protein from an inward-open to occluded state, causing cell contraction and length changes essential for cochlear amplification 2. Salicylate inhibits electromotility by competing for the anion-binding site and preventing conformational transitions 2. Beyond hearing, prestin functions as a weak Cl⁻/HCO₃⁻ antiporter regulating OHC intracellular pH and serves as an elastic element amplifying cardiac myocyte contractility 3. Mutations in SLC26A5 cause autosomal recessive nonsyndromic hearing loss (DFNB61) 4. The p.R130S variant impairs prestin motor kinetics and causes progressive OHC degeneration and congenital hearing loss 4. Gene therapy using engineered OHC-specific enhancers successfully restored hearing in SLC26A5 knockout mice, demonstrating therapeutic potential 5.

Sources cited
1
Prestin is the protein responsible for OHC electromotility and voltage-dependent force generation in cochlear hearing
PMID: 30181355
2
Prestin uses a hybrid voltage sensor combining intrinsic charged residues and extrinsic chloride binding; salicylate inhibits electromotility by displacing chloride
PMID: 34390643
3
Prestin amplifies cardiac myocyte contractility and serves motor functions beyond the inner ear
PMID: 33951436
4
p.R130S SLC26A5 variant causes DFNB61 hearing loss through reduced motor kinetics and progressive OHC degeneration
PMID: 38431907
5
Engineered OHC-specific enhancers (B8) successfully restored hearing in SLC26A5 knockout mice via gene therapy
PMID: 40262614
Disease Associationsβ“˜21
hearing lossOpen Targets
0.67Moderate
hearing loss, autosomal recessiveOpen Targets
0.67Moderate
age-related hearing impairmentOpen Targets
0.48Moderate
deafnessOpen Targets
0.41Moderate
sensorineural hearing lossOpen Targets
0.36Weak
diabetes mellitusOpen Targets
0.35Weak
disorder of earOpen Targets
0.35Weak
diverticular diseaseOpen Targets
0.32Weak
response to antihypertensive drugOpen Targets
0.29Weak
genetic disorderOpen Targets
0.19Weak
type 2 diabetes mellitusOpen Targets
0.17Weak
edemaOpen Targets
0.16Weak
cholelithiasisOpen Targets
0.16Weak
enthesopathyOpen Targets
0.12Weak
Abnormality of the skeletal systemOpen Targets
0.12Weak
Hearing impairmentOpen Targets
0.12Weak
autosomal dominant nonsyndromic hearing lossOpen Targets
0.11Weak
osteoarthritis, kneeOpen Targets
0.11Weak
osteoarthritis, hipOpen Targets
0.11Weak
restless legs syndromeOpen Targets
0.10Suggestive
Deafness, autosomal recessive, 61UniProt
Pathogenic Variants23
NM_198999.3(SLC26A5):c.949del (p.Val317fs)Pathogenic
Autosomal recessive nonsyndromic hearing loss 61|not provided
β˜…β˜…β˜†β˜†2023β†’ Residue 317
NM_198999.3(SLC26A5):c.1236_1252del (p.Ala413fs)Pathogenic
not provided
β˜…β˜†β˜†β˜†2025β†’ Residue 413
NM_198999.3(SLC26A5):c.448C>T (p.Arg150Ter)Pathogenic
not provided
β˜…β˜†β˜†β˜†2025β†’ Residue 150
NM_198999.3(SLC26A5):c.1312-1G>ALikely pathogenic
not provided
β˜…β˜†β˜†β˜†2025
NM_198999.3(SLC26A5):c.1120G>T (p.Glu374Ter)Pathogenic
not provided
β˜…β˜†β˜†β˜†2025β†’ Residue 374
NM_198999.3(SLC26A5):c.2033_2039dup (p.Ser680fs)Likely pathogenic
not provided
β˜…β˜†β˜†β˜†2025β†’ Residue 680
NM_198999.3(SLC26A5):c.1496_1497del (p.Val499fs)Pathogenic
not provided
β˜…β˜†β˜†β˜†2024β†’ Residue 499
NM_198999.3(SLC26A5):c.195del (p.Pro66_Ile67insTer)Pathogenic
not provided
β˜…β˜†β˜†β˜†2024β†’ Residue 66
NM_198999.3(SLC26A5):c.108_109del (p.Asp36fs)Pathogenic
not provided
β˜…β˜†β˜†β˜†2023β†’ Residue 36
NM_198999.3(SLC26A5):c.1986+1G>ALikely pathogenic
not provided
β˜…β˜†β˜†β˜†2023
NM_198999.3(SLC26A5):c.329dup (p.Phe111fs)Pathogenic
not provided
β˜…β˜†β˜†β˜†2023β†’ Residue 111
NM_198999.3(SLC26A5):c.1515-1G>ALikely pathogenic
not provided
β˜…β˜†β˜†β˜†2023
NM_198999.3(SLC26A5):c.818T>A (p.Leu273Ter)Pathogenic
not provided
β˜…β˜†β˜†β˜†2022β†’ Residue 273
NM_198999.3(SLC26A5):c.51T>G (p.Tyr17Ter)Pathogenic
not provided
β˜…β˜†β˜†β˜†2022β†’ Residue 17
NM_198999.3(SLC26A5):c.404-1G>CLikely pathogenic
not provided
β˜…β˜†β˜†β˜†2022
NM_198999.3(SLC26A5):c.855del (p.Lys285fs)Pathogenic
not provided
β˜…β˜†β˜†β˜†2022β†’ Residue 285
NM_198999.3(SLC26A5):c.1904dup (p.Gly636fs)Pathogenic
not provided
β˜…β˜†β˜†β˜†2022β†’ Residue 636
NM_198999.3(SLC26A5):c.293G>C (p.Gly98Ala)Likely pathogenic
not provided
β˜…β˜†β˜†β˜†2022β†’ Residue 98
NM_198999.3(SLC26A5):c.1120-2A>GLikely pathogenic
not provided
β˜…β˜†β˜†β˜†2021
NM_198999.3(SLC26A5):c.1311+1G>TLikely pathogenic
not provided
β˜…β˜†β˜†β˜†2021
View on ClinVar β†—
Related Genes
CPDProtein interaction92%OCM2Protein interaction90%PITPNM1Protein interaction90%OCMProtein interaction90%SLC10A1Protein interaction85%TMC1Protein interaction76%
Tissue Expression6 tissues
Bone Marrow
100%
Lung
38%
Liver
27%
Ovary
25%
Brain
23%
Heart
2%
Gene Interaction Network
Click a node to explore
SLC26A5CPDOCM2PITPNM1OCMSLC10A1TMC1
PROTEIN STRUCTURE
Preparing viewer…
PDB7LGU Β· 2.30 Γ… Β· EM
View on RCSB β†—
Constraintβ“˜
LOEUFβ“˜
0.77LoF Tolerant
pLIβ“˜
0.00Tolerant
Observed/Expected LoF0.59 [0.46–0.77]
RankingsWhere SLC26A5 stands among ~20K protein-coding genes
  • #7,612of 20,598
    Most Researched61
  • #2,061of 5,498
    Most Pathogenic Variants23
  • #6,169of 17,882
    Most Constrained (LOEUF)0.77
Genes detectedSLC26A5
Sources retrieved10 papers
Response timeβ€”
πŸ“„ Sources
10β–Ό
1
Deciphering enhancers of hearing loss genes for efficient and targeted gene therapy of hereditary deafness.
PMID: 40262614
Neuron Β· 2025
1.00
2
[Prestin].
PMID: 17629019
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi Β· 2007
0.90
3
Identification and characterization of amphibian SLC26A5 using RNA-Seq.
PMID: 34294052
BMC Genomics Β· 2021
0.80
4
Physiological and Pathological Functions of SLC26A6.
PMID: 33553213
Front Med (Lausanne) Β· 2020
0.70
5
Outer Hair Cells and Electromotility.
PMID: 30181355
Cold Spring Harb Perspect Med Β· 2019
0.60